The Acute Effect of Physical Activity on Postprandial Blood Glucose in Pregnant Women

NCT03641170 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2021-04-21

No results posted yet for this study

Summary

The aim of the project is to investigate the acute effect of exercise on blood glucose after food consumption. Thereby the investigators wish to achieve knowledge that can improve prevention and treatment of gestational overweight and gestational diabetes mellitus (GDM). This will prevent serious complications during pregnancy and birth, but also long term complications like type 2 diabetes mellitus (T2DM) for both the mother and the offspring.

Inclusion will be 60 pregnant women divided into three groups - normal weight, overweight and obese and women with gestational diabetes. Participants will receive a fixed diet and go through an intervention period with physical activity immediately after each main meal and a control period with inactivity after the meals. Blood glucose will be the main outcome.

Conditions

  • Gestational Diabetes

Interventions

BEHAVIORAL

Physical activity

Interval walking performed after each main meal.

BEHAVIORAL

Inactivity

Inactivity after each main meal.

OTHER

Fixed diet.

Participants will receive a fixed diet through out the intervention period and control period.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Per Ovesen, MD, Prof. · Aarhus University Hospital / University of Aarhus

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-03
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03641170 on ClinicalTrials.gov